Emma Charters, Kai Cheng, Masako Dunn, Caleb Heng, Jamie Loy, Virginia Ricketts, Aaron Luo, Yee Mon Aung, Will Lewin, Dale Howes, Timothy Manzie, Boyang Wan, Jonathan Clark
Patients treated for oral cancer, may experience restricted mouth opening (trismus). Barriers such as cost have limited the utilization of traditional jaw stretching devices, and consequently, patients experience problems with swallowing, oral care, communication, and cancer surveillance. The safety and efficacy of Restorabite™, a new device designed to overcome these barriers, is evaluated prospectively over 12 months. This phase II investigator-led trial included patients with chronic trismus underwent 10-weeks of trismus therapy using Restorabite™...
March 31, 2024: International Journal of Cancer. Journal International du Cancer